Peripheral swelling: FDA reporting patterns
151,425 FDA FAERS reports mention Peripheral swelling. 88,081 reports have a serious outcome flag.
Medicines named as suspect
- Adalimumab: 14,934 reports
- Etanercept: 14,255 reports
- Methotrexate: 11,041 reports
- Tocilizumab: 8,494 reports
- Tofacitinib: 8,174 reports
- Abatacept: 7,979 reports
- Leflunomide: 7,704 reports
- Infliximab: 6,640 reports
- Lenalidomide: 6,600 reports
- Rituximab: 6,578 reports
- Hydroxychloroquine: 6,515 reports
- Certolizumab Pegol: 5,782 reports
FAERS reports describe events reported after a medicine was taken. They do not prove that the medicine caused an event, measure how often a side effect occurs, or estimate personal risk.
Source: FDA FAERS via openFDA. FAERS data through 2026-06-30. Sources, methods, and limitations.